Protease-Catalyzed Synthesis of Water-Soluble Oligohistidine.

Black SP, Liu M, Xia K, Khare SD, Gross RA. Industrial biotechnology (New Rochelle, N.Y.), 3, 140-145.

Rational Design of Stapled Covalent Peptide Modifiers of Oncoprotein E6 from Human Papillomavirus.

Emanuelson C, Naro Y, Shade O, Liu M, Khare SD, Deiters A. ACS chemical biology, 3, 746-757.

Synergistic Multi-Pronged Interactions Mediate the Effective Inhibition of Alpha-Synuclein Aggregation by the Chaperone HtrA1.

Chinchilla P, Wang B, Lubin JH, Yang X, Roth J, Khare SD, Baum J. bioRxiv : the preprint server for biology, , .

Synergistic Multi-Pronged Interactions Mediate the Effective Inhibition of Alpha-Synuclein Aggregation by the Chaperone HtrA1.

Chinchilla P, Wang B, Lubin JH, Yang X, Roth J, Khare SD, Baum J. bioRxiv : the preprint server for biology, , .

Genetic Encoding of Arylazopyrazole Phenylalanine for Optical Control of Translation.

Janosko CP, Shade O, Courtney TM, Horst TJ, Liu M, Khare SD, Deiters A. ACS omega, 29, 26590-26596.

Modeling of ACE2 and antibodies bound to SARS-CoV-2 provides insights into infectivity and immune evasion.

Lubin JH, Markosian C, Balamurugan D, Ma MT, Chen CH, Liu D, Pasqualini R, Arap W, Burley SK, Khare SD. JCI insight, 13, .

Multifaceted interactions mediated by intrinsically disordered regions play key roles in alpha synuclein aggregation.

Khare SD, Chinchilla P, Baum J. Current opinion in structural biology, , 102579.

Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus.

Hernandez NE, Jankowski W, Frick R, Kelow SP, Lubin JH, Simhadri V, Adolf-Bryfogle J, Khare SD, Dunbrack RL Jr, Gray JJ, Sauna ZE. Heliyon, 4, e15032.

Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus.

Hernandez NE, Jankowski W, Frick R, Kelow SP, Lubin JH, Simhadri V, Adolf-Bryfogle J, Khare SD, Dunbrack RL Jr, Gray JJ, Sauna ZE. Heliyon, 4, e15032.

A Bis(imidazole)-based cysteine labeling tool for metalloprotein assembly.

Ahmad R, Tyryshkin AM, Xie L, Hansen WA, Yachnin BJ, Emge TJ, Mashrai A, Khare SD, Knapp S. Journal of inorganic biochemistry, , 112206.